Is LNSR or ICU more profitable?

LENSAR has a net margin of 50.94% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat LENSAR's return on equity. Company Net Margins Return on Equity Return on Assets LENSAR 50.94% -183.19% 42.26% SeaStar Medical -828.62% -146.29% -96.48%

Is ICU or NYXH more profitable?

Nyxoah has a net margin of -543.21% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Nyxoah's return on equity. Company Net Margins Return on Equity Return on Assets SeaStar Medical -828.62% -146.29% -96.48% Nyxoah -543.21% -163.73% -80.24%

Does the media favor ICU or NYXH?

In the previous week, Nyxoah had 3 more articles in the media than SeaStar Medical. MarketBeat recorded 7 mentions for Nyxoah and 4 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.99 beat Nyxoah's score of 0.70 indicating that SeaStar Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nyxoah 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ICU or LUNG more profitable?

Pulmonx has a net margin of -60.09% compared to SeaStar Medical's net margin of -828.62%. Pulmonx's return on equity of -92.94% beat SeaStar Medical's return on equity. Company Net Margins Return on Equity Return on Assets SeaStar Medical -828.62% -146.29% -96.48% Pulmonx -60.09% -92.94% -39.80%

Do analysts rate ICU or DXR?

SeaStar Medical presently has a consensus price target of $8.00, indicating a potential upside of 66.67%. Given SeaStar Medical's higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better valuation & earnings, ICU or DXR?

Daxor has lower revenue, but higher earnings than SeaStar Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SeaStar Medical $1.23M 15.61 -$12.15M -$4.80 N/A Daxor N/A N/A N/A N/A N/A

Is ICU or DXR more profitable?

Daxor has a net margin of 0.00% compared to SeaStar Medical's net margin of -828.62%. Daxor's return on equity of 0.00% beat SeaStar Medical's return on equity. Company Net Margins Return on Equity Return on Assets SeaStar Medical -828.62% -146.29% -96.48% Daxor N/A N/A N/A

SeaStar Medical (ICU) Competitors

$4.80 +0.01 (+0.21%)

Closing price 07/14/2026 04:00 PM Eastern

Extended Trading

$4.78 -0.02 (-0.42%)

As of 07/14/2026 07:26 PM Eastern

Compare

ICU vs. LNSR, ECOR, NYXH, LUNG, and DXR

Should you buy SeaStar Medical stock or one of its competitors? MarketBeat compares SeaStar Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SeaStar Medical include LENSAR (LNSR), electroCore (ECOR), Nyxoah (NYXH), Pulmonx (LUNG), and Daxor (DXR). These companies are all part of the "medical equipment" industry.

How does SeaStar Medical compare to LENSAR?

LENSAR (NASDAQ:LNSR) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends.

LENSAR has a net margin of 50.94% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LENSAR	50.94%	-183.19%	42.26%
SeaStar Medical	-828.62%	-146.29%	-96.48%

LENSAR presently has a consensus target price of $10.00, indicating a potential upside of 73.61%. SeaStar Medical has a consensus target price of $8.00, indicating a potential upside of 66.67%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

SeaStar Medical has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$58.44M	1.21	-$34.28M	-$0.58	N/A
SeaStar Medical	$1.23M	15.61	-$12.15M	-$4.80	N/A

40.2% of LENSAR shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 65.8% of LENSAR shares are owned by insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

LENSAR has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market.

In the previous week, SeaStar Medical had 2 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for SeaStar Medical and 2 mentions for LENSAR. LENSAR's average media sentiment score of 1.44 beat SeaStar Medical's score of 0.99 indicating that LENSAR is being referred to more favorably in the media.

Company	Overall Sentiment
LENSAR	Positive
SeaStar Medical	Positive

Summary

LENSAR beats SeaStar Medical on 11 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to electroCore?

electroCore (NASDAQ:ECOR) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

In the previous week, SeaStar Medical had 3 more articles in the media than electroCore. MarketBeat recorded 4 mentions for SeaStar Medical and 1 mentions for electroCore. SeaStar Medical's average media sentiment score of 0.99 beat electroCore's score of 0.94 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
electroCore	Positive
SeaStar Medical	Positive

electroCore presently has a consensus target price of $18.00, suggesting a potential upside of 192.68%. SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 66.67%. Given electroCore's higher possible upside, research analysts plainly believe electroCore is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

electroCore has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market.

26.7% of electroCore shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 13.8% of electroCore shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

electroCore has a net margin of -44.08% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-44.08%	-1,956.38%	-83.30%
SeaStar Medical	-828.62%	-146.29%	-96.48%

SeaStar Medical has lower revenue, but higher earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	1.59	-$13.97M	-$1.77	N/A
SeaStar Medical	$1.23M	15.61	-$12.15M	-$4.80	N/A

Summary

electroCore beats SeaStar Medical on 8 of the 14 factors compared between the two stocks.

How does SeaStar Medical compare to Nyxoah?

SeaStar Medical (NASDAQ:ICU) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

In the previous week, Nyxoah had 3 more articles in the media than SeaStar Medical. MarketBeat recorded 7 mentions for Nyxoah and 4 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.99 beat Nyxoah's score of 0.70 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nyxoah	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nyxoah has a net margin of -543.21% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
Nyxoah	-543.21%	-163.73%	-80.24%

SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market. Comparatively, Nyxoah has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market.

SeaStar Medical currently has a consensus target price of $8.00, indicating a potential upside of 66.67%. Nyxoah has a consensus target price of $5.96, indicating a potential upside of 277.37%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

SeaStar Medical has higher earnings, but lower revenue than Nyxoah. SeaStar Medical is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	15.61	-$12.15M	-$4.80	N/A
Nyxoah	$11.33M	5.41	-$101.92M	-$2.48	N/A

Summary

Nyxoah beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Pulmonx?

SeaStar Medical (NASDAQ:ICU) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 7.5% of Pulmonx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Pulmonx has a net margin of -60.09% compared to SeaStar Medical's net margin of -828.62%. Pulmonx's return on equity of -92.94% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
Pulmonx	-60.09%	-92.94%	-39.80%

SeaStar Medical has higher earnings, but lower revenue than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	15.61	-$12.15M	-$4.80	N/A
Pulmonx	$90.50M	0.69	-$54M	-$1.30	N/A

SeaStar Medical has a beta of -1.05, suggesting that its share price is 205% less volatile than the broader market. Comparatively, Pulmonx has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market.

SeaStar Medical currently has a consensus target price of $8.00, suggesting a potential upside of 66.67%. Pulmonx has a consensus target price of $5.58, suggesting a potential upside of 277.25%. Given Pulmonx's stronger consensus rating and higher probable upside, analysts plainly believe Pulmonx is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, SeaStar Medical had 2 more articles in the media than Pulmonx. MarketBeat recorded 4 mentions for SeaStar Medical and 2 mentions for Pulmonx. Pulmonx's average media sentiment score of 1.17 beat SeaStar Medical's score of 0.99 indicating that Pulmonx is being referred to more favorably in the news media.

Company	Overall Sentiment
SeaStar Medical	Positive
Pulmonx	Positive

Summary

Pulmonx beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Daxor?

SeaStar Medical (NASDAQ:ICU) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Daxor has a net margin of 0.00% compared to SeaStar Medical's net margin of -828.62%. Daxor's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-828.62%	-146.29%	-96.48%
Daxor	N/A	N/A	N/A

Daxor has lower revenue, but higher earnings than SeaStar Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	15.61	-$12.15M	-$4.80	N/A
Daxor	N/A	N/A	N/A	N/A	N/A

SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market. Comparatively, Daxor has a beta of 0.26, indicating that its share price is 74% less volatile than the broader market.

SeaStar Medical presently has a consensus price target of $8.00, indicating a potential upside of 66.67%. Given SeaStar Medical's higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 51.5% of Daxor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, SeaStar Medical had 2 more articles in the media than Daxor. MarketBeat recorded 4 mentions for SeaStar Medical and 2 mentions for Daxor. SeaStar Medical's average media sentiment score of 0.99 beat Daxor's score of 0.96 indicating that SeaStar Medical is being referred to more favorably in the media.

Company	Overall Sentiment
SeaStar Medical	Positive
Daxor	Positive

Summary

Daxor beats SeaStar Medical on 6 of the 11 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICU vs. The Competition

Export

Metric	SeaStar Medical	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$19.15M	$9.53B	$6.86B	$12.44B
Dividend Yield	N/A	1.62%	2.68%	8.42%
P/E Ratio	-1.00	25.39	26.96	24.38
Price / Sales	15.61	17.88	521.19	91.92
Price / Cash	N/A	112.66	48.59	59.36
Price / Book	1.75	6.04	10.95	6.33
Net Income	-$12.15M	$177.20M	$3.59B	$331.02M
7 Day Performance	-5.51%	0.02%	-1.49%	-0.33%
1 Month Performance	53.35%	6.99%	2.75%	-1.29%
1 Year Performance	-13.98%	13.89%	28.51%	21.30%

SeaStar Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICU SeaStar Medical	3.2761 of 5 stars	$4.80 +0.2%	$8.00 +66.7%	-14.3%	$19.15M	$1.23M	N/A	2	News Coverage Short Interest Decrease
LNSR LENSAR	2.755 of 5 stars	$6.13 -1.0%	$10.00 +63.1%	-55.3%	$76.02M	$58.44M	N/A	110	Positive News Short Interest Decrease
ECOR electroCore	3.2551 of 5 stars	$7.91 -4.5%	$18.00 +127.6%	-17.4%	$68.69M	$32.03M	N/A	50
NYXH Nyxoah	3.7812 of 5 stars	$1.68 -5.1%	$7.00 +316.7%	-79.8%	$68.61M	$11.33M	N/A	110	Short Interest Decrease Gap Up
LUNG Pulmonx	3.2219 of 5 stars	$1.53 +3.4%	$5.58 +264.9%	-44.8%	$62.51M	$90.50M	N/A	250	Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICU) was last updated on 7/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SeaStar Medical (ICU) Competitors

ICU vs. LNSR, ECOR, NYXH, LUNG, and DXR

How does SeaStar Medical compare to LENSAR?

Summary

How does SeaStar Medical compare to electroCore?

Summary

How does SeaStar Medical compare to Nyxoah?

Summary

How does SeaStar Medical compare to Pulmonx?

Summary

How does SeaStar Medical compare to Daxor?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU vs. The Competition

SeaStar Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SeaStar Medical (ICU) Competitors

ICU vs. LNSR, ECOR, NYXH, LUNG, and DXR

How does SeaStar Medical compare to LENSAR?

Is LNSR or ICU more profitable?

Do analysts rate LNSR or ICU?

Which has stronger valuation and earnings, LNSR or ICU?

Do institutionals & insiders believe in LNSR or ICU?

Which has more risk & volatility, LNSR or ICU?

Does the media refer more to LNSR or ICU?

Summary

How does SeaStar Medical compare to electroCore?

Does the media favor ECOR or ICU?

Do analysts prefer ECOR or ICU?

Which has more volatility & risk, ECOR or ICU?

Do insiders and institutionals hold more shares of ECOR or ICU?

Is ECOR or ICU more profitable?

Which has stronger earnings and valuation, ECOR or ICU?

Summary

How does SeaStar Medical compare to Nyxoah?

Does the media favor ICU or NYXH?

Is ICU or NYXH more profitable?

Which has more volatility and risk, ICU or NYXH?

Do analysts rate ICU or NYXH?

Do institutionals and insiders believe in ICU or NYXH?

Which has higher earnings and valuation, ICU or NYXH?

Summary

How does SeaStar Medical compare to Pulmonx?

Do institutionals & insiders have more ownership in ICU or LUNG?

Is ICU or LUNG more profitable?

Which has higher valuation and earnings, ICU or LUNG?

Which has more volatility and risk, ICU or LUNG?

Do analysts recommend ICU or LUNG?

Does the media favor ICU or LUNG?

Summary

How does SeaStar Medical compare to Daxor?

Is ICU or DXR more profitable?

Which has better valuation & earnings, ICU or DXR?

Which has more volatility and risk, ICU or DXR?

Do analysts rate ICU or DXR?

Do institutionals and insiders believe in ICU or DXR?

Does the media refer more to ICU or DXR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICU vs. The Competition

SeaStar Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools